Transcat, Inc.

Transcat, Inc.

101.51
USD
+1.13
(+1.13%)
0.49EPS
180.20P/E
831.54MMarket Cap
Feb 01Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
16.74
18.19
17.74
20.57
21.78
22.36
23.61
23.35
27.34
30.53
31.49
30.31
35.56
38.83
Basic EPS, GAAP
0.56
0.59
0.6
0.65
0.83
0.99
1.1
1.05
1.52
1.42
1.66
1.58
0.58
0.49
Free Cash Flow per Basic Share
0.8
0.14
1
0.33
0.56
0.77
0.68
2.29
1
1
2.35
2.81
2.09
2.46
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
4.48
5.02
5.62
6.16
7.18
8.27
9.09
10.07
11.45
13.04
25.47
30.79
32.21
32.88
Tangible Book Value per Share
1.5
1.44
0.23
0.48
1.83
2.75
2.38
3.26
0.85
2.16
11.27
5.92
0.51
-0.49
Basic Weighted Avg Shares
7
7
7
7
7
7
7
7
7
8
8
9
9
9
Sales/Revenue/Turnover
119
124
122
144
155
161
173
173
205
231
259
278
332
363
Operating Margin (%)
5.66
5.47
5.16
5.51
5.82
6.36
6.27
6.39
6.9
7.05
7.62
6.42
4
3.63
Depreciation Expense
3
3
4
6
6
6
7
8
10
11
14
19
26
28
Net Income, GAAP
4
4
4
5
6
7
8
8
11
11
14
15
5
5
Effective Tax Rate (%)
38.19
37.32
31.35
36.88
25.49
22.63
17.09
21.95
13.72
20.75
25.99
20.8
32.71
32.1
Profit Margin (%)
3.36
3.26
3.38
3.14
3.82
4.44
4.66
4.49
5.55
4.64
5.26
5.21
1.62
1.26
Working Capital
12
15
10
16
19
23
28
24
32
39
72
44
53
61
LT Debt
8
12
19
26
21
19
35
25
55
60
17
52
129
146
Total Equity
30
34
39
43
51
60
67
75
86
100
225
287
301
309
Return on Invested Capital (%)
10.54
9.98
8.3
7.75
9.25
10.23
9.76
8.38
9.93
8.37
7.07
4.76
2.29
1.98
Return on Capital (%)
10.72
10.08
8.28
7.78
9.28
10.22
9.73
8.36
9.8
8.19
7.31
5.12
2.18
1.92
Return on Common Equity (%)
12.91
12.5
11.26
10.99
12.5
12.88
12.73
10.96
14.11
11.5
8.4
5.67
1.83
1.52

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
ST Debt
4
4
5
LT Borrowings
100
110
117
LT Finance Leases
29
28
29
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
686
868
832

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
Total Current Assets
92
96
100
Cash, Cash Equivalents & STI
5
7
6
Accounts Receivable, Net
65
67
70
Inventories
14
15
15
Total Current Liabilities
40
38
39
Payables & Accruals
32
32
32
ST Debt
4
4
5
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.9%
37.72%
4.79%
Free Cash Flow
38.85%
22.11%
-24.18%
Net Income, GAAP
8.18%
2.22%
-62.96%
Sales/Revenue/Turnover
10.68%
13.96%
19.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
67
68
67
77
278
2026
76
82
84
89
332
2027
93
97
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.49
0.36
0.26
0.48
1.58
2026
0.35
0.14
-0.12
0.21
0.58
2027
0.14
0.26
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Jaime A. Irick
Full Time Employees
1,413
Sector
Electronic technology
Industry
Electronic equipment/Instruments
Address
35 Vantage Point Drive Rochester NY United States 14624
IPO Date
Jul 5, 1965
Business
Transcat, Inc. delivers comprehensive calibration and laboratory instrument services across North America and on an international scale. The company's operations are divided into two primary segments: Service and Distribution. The Service segment provides an extensive array of offerings, including calibration, repair, inspection, analytical qualification, preventative maintenance, and consulting. This segment is bolstered by its proprietary asset management software, C3 (Compliance, Control and Cost), which has replaced CalTrak Online. C3 is designed to streamline the management of calibration service workflows and customer instrumentation assets, providing a secure online portal for accessing calibration records and ensuring compliance with quality systems. Through its Distribution segment, Transcat sells and rents a broad selection of professional-grade test, measurement, and control instruments. This includes calibration instruments, electrical testers, and dimensional measuring tools, among others, from numerous leading manufacturers. Value-added services such as instrument calibration, equipment rental, and kitting are also offered. Products are marketed through various channels, including its website, digital and print advertisements, direct sales efforts, and a dedicated inbound call center. Transcat caters to highly regulated sectors, primarily focusing on life sciences, which encompasses pharmaceutical, biotechnology, and medical device companies, as well as other FDA-regulated entities. Additionally, the company serves the aerospace and defense, industrial manufacturing, energy and utilities, and chemical processing industries, all of which demand precision and verification of equipment capabilities. The company has recently made strategic acquisitions, including Essco Calibration Laboratory in August 2025, to expand its service capabilities and geographic footprint. Transcat, Inc. was established in 1964 and maintains its headquarters in Rochester, New York.

Company News

  • Transcat, Inc. (NASDAQ:TRNS) Stock Has Consensus Target Price of $108.33

  • Are You Looking for a Top Momentum Pick? Why Transcat, Inc. (TRNS) is a Great Choice

  • All You Need to Know About Transcat (TRNS) Rating Upgrade to Strong Buy

  • Best Momentum Stocks to Buy for November 6th

  • New Strong Buy Stocks for November 6th

  • Transcat, Inc. (TRNS) Q2 2027 Earnings Call Transcript

  • Transcat (TRNS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Transcat, Inc. (TRNS) Q2 Earnings and Revenues Top Estimates

  • Transcat Q2 Earnings Call Highlights

  • Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion

  • Is the Options Market Predicting a Spike in Transcat Stock?

  • Transcat to Attend Upcoming Investor Conferences in November

  • Conestoga Micro Cap Composite: Q3 2026 Leaders, Laggards, Buys And Sells

  • Can Transcat (TRNS) Keep the Earnings Surprise Streak Alive?

  • Transcat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern Time

  • Is Transcat Inc (TRNS) a Bargain After 3.0% Drop? GF Value Says Undervalued

  • Transcat Holdings: Recent Share Price Weakness Provides A Solid Entry Point

  • Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

  • Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

  • Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS